Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with head and neck cancer for the first time, where their treatment plan includes radiotherapy
- People aged 18 or older
- People who have given written agreement to take part
- People who have not previously had radiotherapy
- People with a life expectancy of more than 3 months
- People whose general health is rated below a certain level on the World Health Organization (WHO) scale (confirm with trial site)
- People whose head and neck cancer has been confirmed through a tissue or cell sample (such as a biopsy)
- People whose condition is stable, with no signs that the cancer has come back or that another cancer is actively growing at the time of the study assessment
- People who are receiving radiotherapy as part of their treatment
- People who are fluent in French
Who may not be able to join:
- People who have not given their consent to participate
- People with a history of another cancer, unless it was basal cell skin cancer or cervical cancer that has been fully treated and cured
- People who have had major surgery beyond lymph node removal as a rescue or salvage treatment
- People who show signs that their cancer has returned, or that another cancer is actively growing at the time of the study assessment
- People who have previously had surgery that caused lasting difficulties with swallowing or eating
- People with an infection that is not currently under control
- People under 18 years of age
- People who are not fluent in French
- People with a psychiatric condition that could interfere with the study or make the results difficult to interpret
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: maxime humbert, MD, University Hospital, Caen
Phone: 0231064640
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
change, neuropathic pain 1
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.